Cervu is building a first of its kind pelvic trainer system to improve quality of life and sexual health for women, evaluated among female cancer survivors with chronic pelvic pain and painful sex.

SonoVascular has developed the SonoThrombectomy™ System, a next-generation ultrasound-facilitated catheter system that treats blood clots more safely and effectively.

This innovative system employs a hybrid mechanical-pharmaco approach, uniquely combining focused ultrasound, microbubbles, and thrombolytic drugs in an integrated catheter to enable precise clot disruption and elimination—without vessel damage, blood loss, or ICU admission.

Microbubbles act as amplifiers under ultrasound activation, mechanically loosening clot fibrin and enhancing drug penetration for superior outcomes.

iNOvodel is a medical technology company commercializing a novel system for delivering inhaled nitric oxide (iNO) therapy.

Our proprietary platform generates highly concentrated iNO using safe, low-cost chemicals and rapidly mixes it to minimize harmful NO₂ formation—offering improved safety, portability, ease of use, and lower cost compared to existing hospital-based systems.

iNOvodel aims to expand iNO therapy to broader patient populations and new clinical settings.

Corvivo Cardiovascular is a commercial-stage regenerative medical device company focused on cardiovascular repair and regeneration products.

Its flagship Natev™ Tricuspid Valve is a regenerative valve for surgical management of tricuspid valve disease, damage, and dysfunction in adult and pediatric patients—now in final stages of FDA review.

Imagine Devices develops Trinity Tube, the first multifunctional neonatal feeding tube that integrates feeding, vital signs, and respiratory monitoring into a single device.

This innovative solution improves safety, reduces clinical workload, and enhances care for premature infants in NICUs worldwide.